L'Oreal SA (OREP.PA)
30 Sep 2016
(The following statement was released by the rating agency) MILAN/LONDON, September 27 (Fitch) Fitch Ratings has affirmed L'Oreal SA's (L'Oreal) Short-Term Issuer Default Rating (IDR) and commercial paper (CP) programme at 'F1+'. The agency has also affirmed L'Oreal USA Inc's CP programme, guaranteed by L'Oreal, at 'F1+'. The ratings continue to reflect the company's strong market position and product portfolio as well as its robust geographical diversification. Also, L'Oreal continues to d
PARIS, July 29 L'Oreal said on Friday it had boosted the pipeline of new products to turn around Chinese face mask provider Magic Holdings after taking a 213 million euro ($237 million) impairment charge on the company's carrying value at the half-year.
* Business investment down 0.2 pct after +2.1 pct in Q1 (Adds L'Oreal CEO, economist, euro zone GDP)
* CEO said it planned to buy a small skincare brand in France, did not give details Source text for Eikon: Further company coverage: (Reporting by Paris Newsroom)
* CEO says France's poor Q2 performance cost the group a percentage point in sales growth Source text for Eikon: Further company coverage: (Reporting by Paris Newsroom)
* L'Oreal CEO says confident about ability to accelerate sales growth in H2 Source text for Eikon: Further company coverage: (Reporting by Paris Newsroom)
* L'oreal CEO says China's Magic suffered from increased competition since when bought business in 2014 Source text for Eikon: Further company coverage: (Reporting by Paris Newsroom)
* Shares down more than 2 percent after H1 results, impairment charges Source text for Eikon: Further company coverage: (Reporting by Paris Newsroom)
PARIS, July 28 French cosmetics giant L'Oreal took a 447 million euro impairment charge in its first half results on the carrying value of two acquisitions, China's Magic Holdings face mask provider and sonic skin care Clarisonic.
PARIS Cosmetics company L'Oreal has agreed to buy IT Cosmetics, a U.S. maker of beauty products for women with severe skin conditions, for $1.2 billion, the French firm said on Friday.